229 related articles for article (PubMed ID: 12188931)
1. The F-box protein SKP2 mediates androgen control of p27 stability in LNCaP human prostate cancer cells.
Lu L; Schulz H; Wolf DA
BMC Cell Biol; 2002 Aug; 3():22. PubMed ID: 12188931
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of Skp2 is correlated with p27-associated cell cycle arrest induced by phenylacetate in human prostate cancer cells.
Shibahara T; Onishi T; Franco OE; Arima K; Sugimura Y
Anticancer Res; 2005; 25(3B):1881-8. PubMed ID: 16158921
[TBL] [Abstract][Full Text] [Related]
3. p27(Kip1) stabilization and G(1) arrest by 1,25-dihydroxyvitamin D(3) in ovarian cancer cells mediated through down-regulation of cyclin E/cyclin-dependent kinase 2 and Skp1-Cullin-F-box protein/Skp2 ubiquitin ligase.
Li P; Li C; Zhao X; Zhang X; Nicosia SV; Bai W
J Biol Chem; 2004 Jun; 279(24):25260-7. PubMed ID: 15075339
[TBL] [Abstract][Full Text] [Related]
4. PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2).
Mamillapalli R; Gavrilova N; Mihaylova VT; Tsvetkov LM; Wu H; Zhang H; Sun H
Curr Biol; 2001 Feb; 11(4):263-7. PubMed ID: 11250155
[TBL] [Abstract][Full Text] [Related]
5. Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells.
Koga H; Harada M; Ohtsubo M; Shishido S; Kumemura H; Hanada S; Taniguchi E; Yamashita K; Kumashiro R; Ueno T; Sata M
Hepatology; 2003 May; 37(5):1086-96. PubMed ID: 12717389
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D inhibits G1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm.
Yang ES; Burnstein KL
J Biol Chem; 2003 Nov; 278(47):46862-8. PubMed ID: 12954644
[TBL] [Abstract][Full Text] [Related]
7. Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest.
Kokontis JM; Hay N; Liao S
Mol Endocrinol; 1998 Jul; 12(7):941-53. PubMed ID: 9658399
[TBL] [Abstract][Full Text] [Related]
8. Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival.
Yang G; Ayala G; De Marzo A; Tian W; Frolov A; Wheeler TM; Thompson TC; Harper JW
Clin Cancer Res; 2002 Nov; 8(11):3419-26. PubMed ID: 12429629
[TBL] [Abstract][Full Text] [Related]
9. Inverse relationship between Skp2 ubiquitin ligase and the cyclin dependent kinase inhibitor p27Kip1 in prostate cancer.
Ben-Izhak O; Lahav-Baratz S; Meretyk S; Ben-Eliezer S; Sabo E; Dirnfeld M; Cohen S; Ciechanover A
J Urol; 2003 Jul; 170(1):241-5. PubMed ID: 12796697
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cells.
Lin R; Wang TT; Miller WH; White JH
Endocrinology; 2003 Mar; 144(3):749-53. PubMed ID: 12586749
[TBL] [Abstract][Full Text] [Related]
11. Androgen suppresses the proliferation of androgen receptor-positive castration-resistant prostate cancer cells via inhibition of Cdk2, CyclinA, and Skp2.
Kokontis JM; Lin HP; Jiang SS; Lin CY; Fukuchi J; Hiipakka RA; Chung CJ; Chan TM; Liao S; Chang CH; Chuu CP
PLoS One; 2014; 9(10):e109170. PubMed ID: 25271736
[TBL] [Abstract][Full Text] [Related]
12. Role of the F-box protein Skp2 in adhesion-dependent cell cycle progression.
Carrano AC; Pagano M
J Cell Biol; 2001 Jun; 153(7):1381-90. PubMed ID: 11425869
[TBL] [Abstract][Full Text] [Related]
13. Degradation of p27(Kip1) at the G(0)-G(1) transition mediated by a Skp2-independent ubiquitination pathway.
Hara T; Kamura T; Nakayama K; Oshikawa K; Hatakeyama S; Nakayama K
J Biol Chem; 2001 Dec; 276(52):48937-43. PubMed ID: 11682478
[TBL] [Abstract][Full Text] [Related]
14. Negative regulation of SCFSkp2 ubiquitin ligase by TGF-beta signaling.
Wang W; Ungermannova D; Jin J; Harper JW; Liu X
Oncogene; 2004 Feb; 23(5):1064-75. PubMed ID: 14676846
[TBL] [Abstract][Full Text] [Related]
15. Androgen-driven prostate epithelial cell proliferation and differentiation in vivo involve the regulation of p27.
Waltregny D; Leav I; Signoretti S; Soung P; Lin D; Merk F; Adams JY; Bhattacharya N; Cirenei N; Loda M
Mol Endocrinol; 2001 May; 15(5):765-82. PubMed ID: 11328857
[TBL] [Abstract][Full Text] [Related]
16. Expression of the F-box protein SKP2 induces hyperplasia, dysplasia, and low-grade carcinoma in the mouse prostate.
Shim EH; Johnson L; Noh HL; Kim YJ; Sun H; Zeiss C; Zhang H
Cancer Res; 2003 Apr; 63(7):1583-8. PubMed ID: 12670908
[TBL] [Abstract][Full Text] [Related]
17. Androgen suppresses proliferation of castration-resistant LNCaP 104-R2 prostate cancer cells through androgen receptor, Skp2, and c-Myc.
Chuu CP; Kokontis JM; Hiipakka RA; Fukuchi J; Lin HP; Lin CY; Huo C; Su LC; Liao S
Cancer Sci; 2011 Nov; 102(11):2022-8. PubMed ID: 21781227
[TBL] [Abstract][Full Text] [Related]
18. Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation.
Kamura T; Hara T; Kotoshiba S; Yada M; Ishida N; Imaki H; Hatakeyama S; Nakayama K; Nakayama KI
Proc Natl Acad Sci U S A; 2003 Sep; 100(18):10231-6. PubMed ID: 12925736
[TBL] [Abstract][Full Text] [Related]
19. Tuberin binds p27 and negatively regulates its interaction with the SCF component Skp2.
Rosner M; Hengstschläger M
J Biol Chem; 2004 Nov; 279(47):48707-15. PubMed ID: 15355997
[TBL] [Abstract][Full Text] [Related]
20. An Rb-Skp2-p27 pathway mediates acute cell cycle inhibition by Rb and is retained in a partial-penetrance Rb mutant.
Ji P; Jiang H; Rekhtman K; Bloom J; Ichetovkin M; Pagano M; Zhu L
Mol Cell; 2004 Oct; 16(1):47-58. PubMed ID: 15469821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
